ArticleHarm reduction journal2025
The potential use of digital technologies to enhance opioid agonist treatment in rural and remote communities of British Columbia, Canada.
Article in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPeople who use drugs (PWUD) and Indigenous-PWUD in rural and remote communities are met with considerable barriers in access to opioid agonist treatments (OAT) in comparison to their urban counterparts. OAT is met with low rates of uptake and retention owing to clinic policies limiting access to take-home doses. Digital technologies may improve access to OAT for PWUD in rural and remote communities. The objective of this study was to understand willingness to use an asynchronous witnessed-dosing phone application among rural and remote PWUD.
methodsQualitative semi-structured interviews were conducted with PWUD in rural and small communities in British Colombia, Canada (n = 32). Participants had to be ≥ 19 years old and have been on a prescribed OAT program within the 1-year of when the study began. A content analysis was completed on interview transcripts based on categories identified by the research team.
resultsParticipants described access barriers to OAT medications, which was contingent upon housing-related factors. Regardless of living in town, in coastal communities, or on Tla'amin Nation treaty lands, participants described accessing OAT medications as restricting, impractical, and stigmatizing. When presented with a potential alternative delivery method via an asynchronous virtual application, participants described potential improvements in not only access to their OAT medications, but overall quality of life through, independence and increased opportunities to engage in day-to-day activities. Participants noted potential difficulties in keeping mobile devices.
conclusionsOur findings help illustrate how current OAT prescribing practices and the challenges with requiring in-person witnessed doses for people living in rural and remote communities, exercising control over OAT patients, ultimately limiting the autonomy of PWUD. There is a clear need to implement virtual OAT programs to improve access to OAT medications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.